Literature DB >> 23014131

Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling.

Cameron Donaldson1, Bradley M Palmer, Michael Zile, David W Maughan, John S Ikonomidis, Henk Granzier, Markus Meyer, Peter VanBuren, Martin M LeWinter.   

Abstract

BACKGROUND: Hypertension (HTN) causes concentric left ventricular remodeling, defined as an increased relative wall thickness or overt left ventricular hypertrophy, and associated diastolic dysfunction. HTN and concentric remodeling are also common precursors to heart failure with a preserved ejection fraction. It is not known whether the myofilament contributes to diastolic dysfunction in patients with concentric remodeling. METHODS AND
RESULTS: Intraoperative myocardial biopsies were obtained in 15 male patients undergoing coronary bypass grafting, all with normal left ventricular ejection fraction and wall motion. Eight patients had a history of HTN and concentric remodeling. Seven without HTN or remodeling served as controls. Myocardial strips were dissected and demembranated with detergent. Isometric tension was measured and sinusoidal length perturbation analysis performed at sarcomere length 2.2 μm and pCa 8 to 4.5. Sinusoidal analysis provides estimates of cross-bridge dynamics, including rate constants of attachment and detachment and cross-bridge attachment time. The normalized isometric tension-pCa relation was similar in HTN and controls. However, cross-bridge attachment time was significantly prolonged at submaximal [Ca(2+)] (pCa ≥6.5) in HTN patients. Analysis of protein phosphorylation revealed ≈25% reduction in phosphorylation of troponin I in HTN patients (P<0.05).
CONCLUSIONS: Compared with controls, patients with HTN and concentric remodeling display prolonged cross-bridge attachment time at submaximal [Ca(2+)] without a change in the tension-pCa relation. Prolonged cross-bridge attachment time implicates altered cross-bridge dynamics as a cause of slowed relaxation in these patients. This finding was associated with reduced phosphorylation of troponin I, suggesting decreased phosphorylation of protein kinase A/G sites as a mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23014131      PMCID: PMC3505876          DOI: 10.1161/CIRCHEARTFAILURE.112.968925

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  47 in total

1.  Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure.

Authors:  Michael R Zile; Stacia M Desantis; Catalin F Baicu; Robert E Stroud; Sheila B Thompson; Catherine D McClure; Shannon M Mehurg; Francis G Spinale
Journal:  Circ Heart Fail       Date:  2011-02-24       Impact factor: 8.790

2.  Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension.

Authors:  B C Aeschbacher; D Hutter; J Fuhrer; P Weidmann; E Delacrétaz; Y Allemann
Journal:  Am J Hypertens       Date:  2001-02       Impact factor: 2.689

3.  Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle.

Authors:  J C Kentish; D T McCloskey; J Layland; S Palmer; J M Leiden; A F Martin; R J Solaro
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

4.  Alterations of myocardial dynamic stiffness implicating abnormal crossbridge function in human mitral regurgitation heart failure.

Authors:  L A Mulieri; W Barnes; B J Leavitt; F P Ittleman; M M LeWinter; N R Alpert; D W Maughan
Journal:  Circ Res       Date:  2002-01-11       Impact factor: 17.367

5.  Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction.

Authors:  Donald E Selby; Bradley M Palmer; Martin M LeWinter; Markus Meyer
Journal:  J Am Coll Cardiol       Date:  2011-07-05       Impact factor: 24.094

6.  Relaxation in hypertrophic cardiomyopathy and hypertensive heart disease: relations between hypertrophy and diastolic function.

Authors:  S F De Marchi; Y Allemann; C Seiler
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

7.  Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice.

Authors:  Olivier Cazorla; Szabolcs Szilagyi; Nicolas Vignier; Guillermo Salazar; Elisabeth Krämer; Guy Vassort; Lucie Carrier; Alain Lacampagne
Journal:  Cardiovasc Res       Date:  2005-12-27       Impact factor: 10.787

8.  Disproportionally impaired microvascular structure in essential hypertension.

Authors:  Ashkan Eftekhari; Ole Norling Mathiassen; Niels Henrik Buus; Ole Gotzsche; Michael John Mulvany; Kent Lodberg Christensen
Journal:  J Hypertens       Date:  2011-05       Impact factor: 4.844

9.  Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction.

Authors:  Mario Kasner; Dirk Westermann; Begoña Lopez; Regina Gaub; Felicitas Escher; Uwe Kühl; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  J Am Coll Cardiol       Date:  2011-02-22       Impact factor: 24.094

Review 10.  Protein kinase C in heart failure: a therapeutic target?

Authors:  Suresh Selvaraj Palaniyandi; Lihan Sun; Julio Cesar Batista Ferreira; Daria Mochly-Rosen
Journal:  Cardiovasc Res       Date:  2009-01-24       Impact factor: 13.081

View more
  19 in total

1.  Right ventricular protein expression profile in end-stage heart failure.

Authors:  Yan Ru Su; Manuel Chiusa; Evan Brittain; Anna R Hemnes; Tarek S Absi; Chee Chew Lim; Thomas G Di Salvo
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

2.  Could Modification of Titin Contribute to an Answer for Heart Failure With Preserved Ejection Fraction?

Authors:  Martin M LeWinter; Michael R Zile
Journal:  Circulation       Date:  2016-09-14       Impact factor: 29.690

3.  Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.

Authors:  Michael R Zile; Catalin F Baicu; John S Ikonomidis; Robert E Stroud; Paul J Nietert; Amy D Bradshaw; Rebecca Slater; Bradley M Palmer; Peter Van Buren; Markus Meyer; Margaret M Redfield; David A Bull; Henk L Granzier; Martin M LeWinter
Journal:  Circulation       Date:  2015-01-30       Impact factor: 29.690

4.  Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism.

Authors:  Mark Y Jeong; Ying H Lin; Sara A Wennersten; Kimberly M Demos-Davies; Maria A Cavasin; Jennifer H Mahaffey; Valmen Monzani; Chandrasekhar Saripalli; Paolo Mascagni; T Brett Reece; Amrut V Ambardekar; Henk L Granzier; Charles A Dinarello; Timothy A McKinsey
Journal:  Sci Transl Med       Date:  2018-02-07       Impact factor: 17.956

5.  Omecamtiv Mecarbil Slows Myosin Kinetics in Skinned Rat Myocardium at Physiological Temperature.

Authors:  Thinh T Kieu; Peter O Awinda; Bertrand C W Tanner
Journal:  Biophys J       Date:  2019-04-25       Impact factor: 4.033

6.  Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function.

Authors:  Paola C Rosas; Yang Liu; Mohamed I Abdalla; Candice M Thomas; David T Kidwell; Giuseppina F Dusio; Dhriti Mukhopadhyay; Rajesh Kumar; Kenneth M Baker; Brett M Mitchell; Patricia A Powers; Daniel P Fitzsimons; Bindiya G Patel; Chad M Warren; R John Solaro; Richard L Moss; Carl W Tong
Journal:  Circ Heart Fail       Date:  2015-03-04       Impact factor: 8.790

7.  Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction.

Authors:  K Elisabeth Runte; Stephen P Bell; Donald E Selby; Tim N Häußler; Takamuru Ashikaga; Martin M LeWinter; Bradley M Palmer; Markus Meyer
Journal:  Circ Heart Fail       Date:  2017-08       Impact factor: 8.790

8.  Mechanisms of diastolic dysfunction in heart failure with a preserved ejection fraction: If it's not one thing it's another.

Authors:  Martin M LeWinter; Markus Meyer
Journal:  Circ Heart Fail       Date:  2013-11       Impact factor: 8.790

9.  The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice.

Authors:  Peiheng Gan; Catalin Baicu; Hirofumi Watanabe; Kristy Wang; Ge Tao; Daniel P Judge; Michael R Zile; Takako Makita; Rupak Mukherjee; Henry M Sucov
Journal:  Hum Mol Genet       Date:  2021-01-06       Impact factor: 6.150

10.  Microtubules Increase Diastolic Stiffness in Failing Human Cardiomyocytes and Myocardium.

Authors:  Matthew A Caporizzo; Christina Yingxian Chen; Ken Bedi; Kenneth B Margulies; Benjamin L Prosser
Journal:  Circulation       Date:  2020-01-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.